BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Deals

  Vectalys and FlashCell Announce Merger to Create Flash Therapeutics, New Gene Therapy Company Based on Lentiviral Platforms and Bioproduction Technologies

  Vectalys and FlashCell today announced that they have merged to create Flash Therapeutics.

  May 16, 2018

   · 

  5 min read
• Business

  Agilent Technologies Announces Cash Dividend of 14.9 Cents per Share

  Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 14.9 cents per share of common stock.

  May 16, 2018

   · 

  1 min read
• Drug Development

  Pi-Cardia Initiates First-in-Human Study With Novel Non-Implant Based Treatment of Aortic Stenosis

  Pi-Cardia Ltd., announced today that it recently started its First-in-Human study with its Leaflex(TM) Performer catheter system.

  May 16, 2018

   · 

  3 min read
• Business

  Eiger Announces Expanded License Agreement with Merck for Investigational Candidate Lonafarnib and Collaboration with The Progeria Research Foundation (PRF)

  Plans to Seek FDA Guidance for Potential Hutchinson-Gilford Progeria Syndrome (HGPS or Progeria) Indication

  May 16, 2018

   · 

  7 min read
• Business

  Liquidia Technologies Appoints Jeri Thomas as Senior Vice President, Commercial

  Ms. Thomas will have responsibility for developing and leading Liquidia’s commercial plans, with initial focus on LIQ861, an inhaled dry powder formulation of treprostinil currently being evaluated in a pivotal Phase 3 safety trial for the treatment of pulmonary arterial hypertension.

  May 16, 2018

   · 

  3 min read
• FDA

  Castle Creek Pharmaceuticals Receives FDA Rare Pediatric Disease Designation for Diacerein 1% Ointment for Epidermolysis Bullosa

  Safety and efficacy of investigational drug is being evaluated in DELIVERS study for rare disorder that leads to extremely fragile skin.

  May 16, 2018

   · 

  3 min read
• Genetown

  DDN and Parabricks Announce Groundbreaking Solution for GPU Acceleration of Genome Analysis

  New GPU and Storage Configuration Capable of Analyzing 1,500 Genomes a Week, Accelerating Precision Medicine Workflows by 100x.

  May 16, 2018

   · 

  4 min read
• Drug Development

  Rapid Medical: First Patient Enrolled to the TIGER Pivotal Clinical Study

  Data from the study will be submitted to the FDA in support of Market Clearance for TIGERTRIEVER in the U.S.

  May 16, 2018

   · 

  1 min read
• Biotech Beach

  GT Biopharma Announces Update to OXS-3550 IND Filing, Its Most Advanced Tri-specific Killer Engager

  Expected to file the Investigational New Drug Application for OXS-3550, the Company’s most advanced Tri-specific Killer Engager product candidate, in mid-2018.

  May 16, 2018

   · 

  3 min read
• Job Trends

  Thermo Fisher Scientific Installs First Glacios Cryo-Electron Microscope for Drug Discovery and Development

  Breakthrough platform optimizes productivity and expands cryo-EM entry path for a broader range of researchers

  May 16, 2018

   · 

  2 min read